Lu Xie

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumoursChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 09, 2023
Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial.

Jie Xu, Lu Xie, Xin Sun

|Jun 08, 2022
Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma.

Jiayong Liu, Tian Gao, Zhichao Tan

|Apr 15, 2021
Venous Tumor Thrombus in Primary Bone Sarcomas in the Pelvis: A Clinical and Radiographic Study of 451 Cases.

Haijie Liang, Wei Guo, Xiaodong Tang

|Jun 18, 2020
Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study.

Lu Xie, Jie Xu, Xin Sun

|Feb 06, 2020
Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma.

Lu Xie, Jie Xu, Xin Sun

|Dec 19, 2018
Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.

Lu Xie, Jie Xu, Xin Sun

Pageof 1

Frequent Collaborators

3 joint publications

Wei Guo

2 joint publications

Xin Sun

2 joint publications

Jie Xu

1 joint publications

Xiaowei Li